Seeking to treat the stymptoms or Ulcerative Colitus, Parabiotic R&D has patented a combined treatment modality to treat, re-establish, and maintain the GI tract.

• Presenter: Ira Trachtman, Founder and President
• Commercial Catalyst: Caroline Hoedemaker and Paul Jeffrey
• Defined Milestone: Re – define position in competitive space
• Targeted Completion: 1 month